BR112022018377A2 - Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos - Google Patents

Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos

Info

Publication number
BR112022018377A2
BR112022018377A2 BR112022018377A BR112022018377A BR112022018377A2 BR 112022018377 A2 BR112022018377 A2 BR 112022018377A2 BR 112022018377 A BR112022018377 A BR 112022018377A BR 112022018377 A BR112022018377 A BR 112022018377A BR 112022018377 A2 BR112022018377 A2 BR 112022018377A2
Authority
BR
Brazil
Prior art keywords
biocomposites
collagen
probiotics
extracellular polysaccharide
bacterial extracellular
Prior art date
Application number
BR112022018377A
Other languages
English (en)
Inventor
Olivares Martín Mónica
Bañuelos Hortigüela Óscar
Manuel Domínguez Vera José
González Garnica Ana
Manuel Delgado López José
Sabio Rodríguez Laura
Belén Ramírez Rodríguez Gloria
Original Assignee
Biosearch S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch S A filed Critical Biosearch S A
Publication of BR112022018377A2 publication Critical patent/BR112022018377A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3637—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

BIOCOMPÓSITOS COMPREENDENDO PROBIÓTICOS, COLÁGENO E POLISSACARÍDEO EXTRACELULAR BACTERIANO E USOS DOS MESMOS. A invenção se refere a biocompósitos biológicos que compreendem um andaime de colágeno contendo probióticos aprisionados no andaime de colágeno e exopolissacarídeos. A invenção também se refere a métodos para obter os biocompósitos, bem como ao uso de biocompósitos na medicina e, mais em particular, no tratamento da vaginose bacteriana.
BR112022018377A 2020-03-16 2021-03-15 Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos BR112022018377A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382195 2020-03-16
PCT/EP2021/056471 WO2021185728A1 (en) 2020-03-16 2021-03-15 Biocomposites comprising probiotics, collagen and bacterial extracellular polysaccharide and uses thereof

Publications (1)

Publication Number Publication Date
BR112022018377A2 true BR112022018377A2 (pt) 2022-11-08

Family

ID=70108144

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022018377A BR112022018377A2 (pt) 2020-03-16 2021-03-15 Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos

Country Status (5)

Country Link
US (1) US20230135760A1 (pt)
EP (1) EP4121073B1 (pt)
CN (1) CN115361963A (pt)
BR (1) BR112022018377A2 (pt)
WO (1) WO2021185728A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113881595B (zh) * 2021-10-09 2023-08-25 湖北工业大学 一种包含蛋白纤维的乳酸菌发酵剂及其制备方法
CN114767922B (zh) * 2022-03-15 2023-09-12 青岛大学 搭载益生菌的透明质酸水凝胶及其制备方法和应用
CN114588253B (zh) * 2022-04-27 2022-12-09 云南康旭生物科技有限公司 用于修复和预防阴道粘膜衰老的药物组合物及其制剂
CN116285178B (zh) * 2023-02-20 2024-06-25 蚌埠医学院 一种土壤杆菌胞外多糖食品包装膜的制备方法及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5163955A (en) 1991-01-24 1992-11-17 Autogenics Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US6379710B1 (en) 1996-12-10 2002-04-30 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
DE60031461T2 (de) 1999-12-22 2007-08-23 Acell, Inc., Cambridge Zusammensetzung zur Geweberegeneration
MXPA03005465A (es) 2000-12-18 2004-10-14 Probiohealth Llc Compuestos probioticos derivados de la cepa ke01 de lactobacillus casei.
AU2003242763B2 (en) 2002-06-28 2008-02-21 Biosearch, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
EP1593376A1 (en) 2004-05-04 2005-11-09 Warner-Lambert Company LLC Improved pullulan capsules
CA2682752C (en) 2007-04-05 2015-07-07 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
JP5585769B2 (ja) * 2009-05-15 2014-09-10 ダイソー株式会社 腸管免疫賦活能を有する乳酸菌に対する効果促進剤
ITMI20130794A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
US10093749B2 (en) * 2013-09-19 2018-10-09 Nitto Pharmaceutical Industries, Ltd. Exopolysaccharide produced by lactic acid bacterium
EP3462917A4 (en) * 2016-05-29 2020-01-08 The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) PROCESS FOR PRODUCING BACTERIAL COMPOSITIONS
US20210290736A1 (en) * 2018-07-16 2021-09-23 Lonza Consumer Health Inc. Collagen and Cell Matter Supplement and Method for Administering Same

Also Published As

Publication number Publication date
CN115361963A (zh) 2022-11-18
US20230135760A1 (en) 2023-05-04
EP4121073A1 (en) 2023-01-25
EP4121073B1 (en) 2024-07-03
WO2021185728A1 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
BR112022018377A2 (pt) Biocompósitos compreendendo probióticos, colágeno e polissacarídeo extracelular bacteriano e usos dos mesmos
BR112018076554A2 (pt) método para diferenciar células progenitoras, para cultivar células-tronco epiteliais, para triagem de um fármaco ou cosmético terapêutico ou profilático, para induzir a quiescência das células-tronco lgr5+ e para obtenção de uma população de células enriquecida em eecs, meio de diferenciação, organoide, composição, uso de um organoide ou uma célula derivada, formulação farmacêutica, população de células-tronco quiescentes, inibidor da bmp, e, ativador da bmp.
BR112018003316A2 (pt) compostos e métodos para entrega transmembrana de moléculas
Fadilah et al. Antioxidant biomaterials in cutaneous wound healing and tissue regeneration: A critical review
BR112016027830A2 (pt) composições de fibra e de carboidrato, produto alimentício, métodos de produção de composição de fibra, de elaboração de composição de carboidrato misturada, de redução do índice glicêmico e de inibição da elevação do nível de açúcar no sangue, composição cosmética, uso da composição de fibra e composição
BR112015026601A2 (pt) método para um ensaio de triagem de fármaco à base de células e o uso do mesmo
BR112016027887A2 (pt) composições de fibra e de carboidrato, produto alimentício, métodos para produzir uma composição de fibra, para produzir uma composição de carboidratos misturada, método para reduzir o índice glicêmico, método para inibir a elevação do nível de açúcar no sangue, composição cosmética, uso da composição e composição
BR112016023304A2 (pt) célula hospedeira recombinante engendrada para superexpressar proteínas auxiliares
BR112017011956A2 (pt) composição de fraturamento hidráulico, método para fazer e uso da mesma
BR112017008117A2 (pt) suporte de biomaterial para regenerar a mucosa oral
BR112017021191A2 (pt) um extrato de indigo naturalis e um processo para preparar o mesmo
CL2008002486A1 (es) Comprimido divisible de liberacion modificada que comprende glicazida, un derivado de celulosa elegido entre: hmc, hec, hpc y/o hpmc y un aglutinante elegido entre: maltodextrina, polividona o hpmc; uso para tratar diabetes.
BR102018073515A2 (pt) processo de obtenção de matriz extracelular de pele de tilápia (oreochromis niloticus) e uso da matriz extracelular de tilápia
BR112022000264A2 (pt) Método para carregar micro-organismos em biomateriais multifásicos
WO2015031347A3 (en) Cross-linked platelet material
BR112018002036A2 (pt) método para o controle das pragas de um vegetal de algodão e utilização de um ou mais componentes da árvore de ginkgo
BR112017019189A2 (pt) agente terapêutico celular para tratamento de câncer e terapia de combinação com o mesmo
BR112022021259A2 (pt) Rotavírus recombinante, composição imunogênica, métodos para induzir uma resposta imune protetora contra rotavírus e um coronavírus e para produzir um rotavírus recombinante, e, sistema de expressão de rotavírus recombinante
BR112018012070A2 (pt) método para a produção de tecidos/ órgãos utilizando células sanguíneas
BR112017020013A2 (pt) método para preparação de um substituto da pele, substituto da pele, substituto dérmico, enxerto, enxerto para uso, e kit para implementação do método
BR112015020066A8 (pt) composição na forma de uma emulsão óleo-em-água, processo cosmético para tratar e/ou cuidar das matérias queratínicas humanas, processo cosmético para tratar a transpiração humana, dispositivo de distribuição e uso de uma composição
BR112021021557A2 (pt) Corpos de cetona confinados em microesferas
BR112018006152A2 (pt) uso de células matriciais, processo ?in vitro? para preparar um microfolículo de cabelo, microfolículo de cabelo, uso de um microfolículo de cabelo e processo de triagem de produtos
BR112018005847A2 (pt) composição de lipídeo de planta para estimular o crescimento de cabelo, método para estimular o crescimento de cabelo e uso dos referidos lipídeos de planta
AR104371A1 (es) Procedimiento para la preparación de una composición que comprende fibras proteicas